drugset / Trial / NCT00836576
Benazepril HCl 40 mg Tablets, Fasting
RandomizedCrossoverOpen-labelOther
Summary
The objective of this randomized, single-dose, two-way crossover evaluation is to compare the oral bioavailability of a test benazepril HCl formulation (TEVA Pharmaceutical Industries Ltd.) to an equivalent oral dose of the commercially available benazepril HCl (Lotensin®, Novartis Pharmaceuticals Corporation) in a test population of 40 adults under fasting conditions.
Timeline
- Start
- 2001-02
- Primary completion
- 2001-03
- Completion
- 2001-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Benazepril | Unknown | 40 mg | Oral |
Indications
No indication recorded.